Wednesday, April 15, 2026
wellness India Expo
Home Tags Therapeutics

Tag: Therapeutics

Bharat Biotech’s Nucelion collaborates with Pandorum Technologies to advance exosome-driven tissue...

By leveraging Nucelion Therapeutics’ manufacturing capabilities, the partnership supports regional supply and regulatory readiness, marking a strategic step forward

Bürkert Fluid Control Systems invests in Green Elephant Biotech to drive...

This partnership should enable more cost-effective production of therapeutics and facilitate access to the latest biopharmaceutical trends.

Immuneel Therapeutics launches Qartemi, India’s first global CAR T-cell therapy for...

Qartemi® is India’s first global CAR T-cell therapy, locally manufactured at Immuneel’s state-of-the-art facility in Bangalore, offering lasting remission for relapsed/refractory B-cell Non-Hodgkin’s Lymphoma

Lupin Digital Health partners Medicover Hospitals for comprehensive post-discharge cardiac care

This groundbreaking partnership aims to reshape cardiac care in India, offering at-home rehabilitation, powered by digital therapeutics

GSK acquires oligonucleotide drug startup Elsie

This follows a successful research collaboration with Elsie, announced in July 2023, in which GSK was able to explore and validate the technology

Biocon Biologics obtains US-FDA approval for biosimilar Aflibercept for Yesafili

A significant milestone for the company marking its entry into ophthalmology, a new therapeutic area in the United States

Lupin Digital Health introduces Digital Therapeutics Certificate for Cardiologists

This collaboration is crucial in ensuring top-notch care and enhancing outcomes, all from the convenience of patients' homes

CSIR-CDRI collaborates with Bengaluru based startup to develop novel therapeutics for...

The collaboration will entail the use of advanced artificial intelligence and computational tools developed at Sravathi AI to design novel chemical entities (NCEs) with anti-cancer properties

Ultragenyx’s UX053 Phase I/II study termination a minor setback for mRNA...

The study was terminated due to reasons unrelated to safety concerns, although the specific rationale has not been disclosed by the biopharmaceutical company

UW-Madison Global Health Institute partners Ella Foundation to establish first-ever ‘UW-Madison...

Partnership expands the Wisconsin Idea by providing interdisciplinary collaborations with UW-Madison, the Ella Foundation, and Bharat Biotech